Education and training: Practice makes perfect

American Journal of Clinical Pathology

Volumn 118, Issue 2, 2002, Pages 167-169

  Wilson, Michael L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CONTINUING EDUCATION; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; LABORATORY TEST; MEDICAL EDUCATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKILL; EDUCATION; LABORATORY PERSONNEL; MYCOLOGY; NOTE;

EVIDENCE-BASED MEDICINE; LABORATORY PERSONNEL; MYCOLOGY;

EID: 0036675833     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RV7D-3A2R-W9QH-WG0D     Document Type: Editorial

References (17)

1. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard. M7-A5. Wayne, PA: NCCLS; 2000.
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; Approved standard. M2-A7. Wayne, PA: NCCLS; 2000.
3. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard. M11-A5. Wayne, PA: NCCLS; 2000.
4. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard. M27-A. Wayne, PA: NCCLS; 1997.
5. Jones RN, for the College of American Pathologists Microbiology Resource Committee. Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of American Pathologists Microbiology Surveys Program. Arch Pathol Lab Med. 2001;125:1285-1289.
6. Association of State and Territorial Public Health Laboratory Directors and Centers for Disease Control and Prevention. Mycobacterium tuberculosis: assessing your laboratory. Atlanta, GA: Centers for Disease Control and Prevention; 1995.
7. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 1.2, May 2000: terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbioi Infect. 2000;6:503-508.
8. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 3.1, June 2000: determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect. 2000;6:509-515.
9. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 2.1, August 2000: determination of antimicrobial susceptibility test breakpoints. Clin Microbiol Infect. 2000;6:570-572.
10. Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiokgy. 7th ed. Washington, DC: ASM Press; 1999.
11. Isenberg HD, ed. Clinical Microbiology Procedures Handbook. Washington, DC: ASM Press; 1992.
12. Rosner ER, Reiss E, Warren NG, et al. Evaluation of the status of laboratory practices and the need for continuing education in medical mycology. Am J Clin Pathol. 2002;118:278-286.
13. McGrath PD, Wennberg DE, Dickens JD, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-3144.
14. Katz JN, Losina E, Barrett J, et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2001;83-A:1622-1629.
15. Schrag D, Cramer LD, Bach PB, et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000;284:3028-3035.
16. Ellis SG, Dushman-Ellis SJ. Accreditation of hospitals for percutaneous coronary intervention on the basis of volume or clinical outcome using MEDPAR data sets: effect on patient mortality, cost and treatment accessibility. J Invasive Cardiol. 2000;12:464-471.
17. Infectious Diseases Society of America. Policy statement on consolidation of clinical microbiology laboratories. Clin Infect Dis. 2001;32:604.